
The authors report preliminary results from a prospective zzso study zzso Carcinoma zzso 2003 German Society of zzso Oncology and zzso Children's Oncology Group zzso 

From 2003 to 2010, 45 patients zzso zzso zzso including 1 patient with stage II zzso and 44 patients with stage zzso zzso were recruited to the zzso The patient with stage II disease received zzso zzso grays zzso The patients with stage zzso disease received 3 courses of zzso chemotherapy with zzso zzso and zzso zzso The cumulative zzso dose was 54 zzso in 5 patients, who achieved complete zzso after zzso chemotherapy, and zzso zzso in the remaining 40 zzso All patients received zzso zzso during the first week and last week of zzso After zzso all patients received zzso beta for 6 zzso zzso response was evaluated by magnetic resonance imaging studies and zzso zzso zzso zzso 

After the completion of treatment, 43 of 45 patients were in complete zzso In 2 patients, only a partial response was zzso followed by distant zzso (1 zzso or local progression and distant zzso (1 zzso 6 months and 10 months after diagnosis, zzso Another patient developed a solitary pelvic bone zzso 21 months after zzso After a median follow-up of 30 months zzso zzso zzso the zzso survival rate was zzso and the overall survival was zzso Acute toxicity consisted mainly of zzso zzso and zzso and late toxicity consisted of hearing loss and zzso 

Combined therapy with zzso chemotherapy, zzso and zzso beta was well tolerated and resulted in a very good outcome that was superior to the outcomes of published results from all other pediatric zzso study zzso 

